返回
Inhibikase Therapeutics Inc（IKT）價格
IKT 股價走勢圖
IKT 財務
Inhibikase Therapeutics Inc
$1.67
1.82%
$0.03
收盤價：Feb 13, 16:00:00 GMT-5
$1.65
-1.19%
$-0.02
盤後：Feb 13, 20:00:00 GMT-5
關鍵數據
前收市價
$1.64
開盤價
$1.64
當日範圍
$1.64 - $1.73
52週區間
$1.33 - $3.32
交易量
218.2K
平均成交量
612.8K
每股盈餘 (TTM)
-1.15
股息收益率
--
市值
$199.4M
什麼是 IKT？
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).